Free Trial

Moleculin Biotech (MBRX) Insider Trading & Ownership

Moleculin Biotech logo
$2.45
-0.15 (-5.77%)
(As of 11/1/2024 ET)

Moleculin Biotech (NASDAQ:MBRX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
7.10%
Number Of
Insiders Buying
(Last 12 Months)
3
Amount Of
Insider Buying
(Last 12 Months)
$159,990.30
Number Of
Insiders Selling
(Last 12 Months)
0
Get MBRX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Moleculin Biotech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

MBRX Insider Buying and Selling by Quarter

Moleculin Biotech Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/26/2023Jonathan P FosterCFOBuy1,932$10.35$19,996.20  
12/26/2023Robert E GeorgeDirectorBuy966$10.35$9,998.10  
12/26/2023Walter V KlempCEOBuy12,560$10.35$129,996.00  
(Data available from 1/1/2013 forward)

MBRX Insider Trading Activity - Frequently Asked Questions

The list of insiders at Moleculin Biotech includes Jonathan P Foster, Robert E George, and Walter V Klemp. Learn more on insiders at MBRX.

7.10% of Moleculin Biotech stock is owned by insiders. Learn more on MBRX's insider holdings.

The following insiders have purchased MBRX shares in the last 24 months: Jonathan P Foster ($19,996.20), Robert E George ($9,998.10), and Walter V Klemp ($296,115.00).

Insiders have purchased a total of 25,638 MBRX shares in the last 24 months for a total of $326,109.30 bought.



This page (NASDAQ:MBRX) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners